Jonathan G. Drachman, CMO & EVP, R & D at SEATTLE GENETICS INC /WA (SGEN), sold 1,241 shares at $53.25 ($66K) on 2014-02-20, disclosed to the SEC on 2014-02-24.
Scheduled sale ($66k) by CMO & EVP, R & D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NLTX | BUY | 2021-06-07 | $475K | — | Filing → |
| NLTX | BUY | 2019-12-20 | $2.0M | — | Filing → |
| NLTX | BUY | 2019-09-11 | $1.6M | — | Filing → |